期刊文献+

肺淋巴管肌瘤病一例

原文传递
导出
摘要 肺淋巴管肌瘤病(PLAM)是一种原因不明的、罕见的且持续发展的弥漫性肺部疾病,目前认为尚无特效疗法。
出处 《中国呼吸与危重监护杂志》 CAS 2014年第3期303-305,共3页 Chinese Journal of Respiratory and Critical Care Medicine
  • 相关文献

参考文献13

  • 1Burrell LST, Ross JM. A case of chylous effusion due to leiomyosacoma. Br J Tuberc, 1937,31:382 39.
  • 2Ye L, Jin M, Bai C. Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in China's Mainland. Respir Med,2010,104: 1521-1526.
  • 3Johnson SR. Lymphangioleiomyomatosis. Eur Respir J, 2006,27: 1056-1065.
  • 4胡红,赵会泽,段晋庆,刘又宁.肺淋巴管肌瘤病一例[J].中华结核和呼吸杂志,1998,21(6):376-377. 被引量:27
  • 5Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax, 1999,54: 254-264.
  • 6Baldi BG, Medeiros Junior P, Pimenta SP, et al. Evolution of pulmonary funetion after treatment with goserelin in patients with lymphangioleiomyomatosis. J Bras Pneumol,2011,37 : 375-379.
  • 7Oprescu N, MeCormaek FX, Bymes S, et al. Clinical predictors of mortality and eause of death in lymphangioleiomyomatosis: a population-based registry. Lung,2013,191 : 35-42.
  • 8Taveira-Dasilva AM, Moss J. Optimizing treatments for lyphangioleiomyomatosis. J Expert Rev Respir Med ,2012 ,6 :267-276.
  • 9Moua T, Olson E J, Jean H CS, et al. Resolution of chylous puhnonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy. Am J Respir Crit Care Med,2012,186 : 389-390.
  • 10Barrera P,Simons SO, Luijk B, et al. Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis. Ann Am Thorac Soe ,2013,10 : 408-409.

二级参考文献19

  • 1龚俊辉,Kell.,KV.肺淋巴管肌瘤病:附一例报告[J].中华内科杂志,1993,32(5):313-315. 被引量:24
  • 2易祥华,朱美芳,史景云,张韵,钟慈声.肺淋巴管平滑肌瘤病的光镜和电镜观察[J].电子显微学报,2005,24(6):574-577. 被引量:6
  • 3Kalassian KG, Doyle R, Kao P, et al. Lymphangioleiomyomatosis: new in- sights. AmJ Respir Crit Care Med, 1997, 155(4): 1183-1186.
  • 4Folpe AL. Neoplasms with perivascular epithelioid cell differentiation (PEComas). In: Christopher DM ed. World Health Organization Classifica- tion of tumors. Pathology & Genetics: Tumours of soft Tissue and bone. IARCpress Lyon, 2002. 221-222.
  • 5Miyake M, Tateishi U, Maeda T, et al. Pulmonary Lymphangioleimyomatosis in a male patient with tuberous sclerosis complex. Radiat Med, 2,005, 23(7): 525-527.
  • 6Aubry MC, Myers JL, Ryn JH, et al. Pulmonary lymphangiomyomatosis in a man. AmJ Res Crit Care Med, 2000, 162(5): 749-752.
  • 7Crooks DM, DeCastre RM, Pacheco-Rodriguez G, et al. Molecular and ge- netic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Nail Acad Sci USA, 2004, 101 (50): 17462-17467.
  • 8Taveira-Dasilva AM, Steagall WK, Moss J. Therapeutic options for lymphan- gioleiomyomatosis (LAM): where we are and where we are going. F1000 Med Rep, 2009, 1(93): 1-11.
  • 9Kwiatkowski DJ. Tuberous sclerosis: from tuber to mTOR. Ann Hum Genet, 2003, 67(1): 87-96.
  • 10Kpodonu J, Massad MG, Chaer RA, et aL The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant, 2005, 24(9): 1247-1253.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部